Eli Lilly has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due ...

Eli Lilly (NYSE:LLY) has decided to stop one of its obesity drug combination trials, pressing pause on a study that paired ...

US pharma major Eli Lilly has halted a study of an experimental drug, bimagrumab, designed to prevent obesity patients from ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

LONDON (Reuters) -AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients ...

Tylenol maker Kenvue is reeling after unsupported claims that its popular drug causes autism. Kennedy is unlikely to stop ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a ...

Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...

The 43-year-old retired tennis champ showcased her substantial weight loss in a animal-print teddy over black leggings, ...

The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Tennis icon Serena Williams appeared irked by the decor choice of an unnamed New York City hotel after she spotted a cotton ...

Serena Williams, the retired tennis champion, expressed visible discomfort over a cotton plant she encountered at a New York ...